Upadacitinib in patients with resistant atopic dermatitis: a retrospective case-series

J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1499-1500. doi: 10.1111/jdv.18139. Epub 2022 Apr 28.

Authors

G Dal Bello¹, D Schena¹, G Girolomoni¹

Affiliation

¹ Section of Dermatology, Department of Medicine, University of Verona, Verona, Italy.

PMID: 35398938
DOI: 10.1111/jdv.18139

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use
Dermatitis, Atopic* / drug therapy
Heterocyclic Compounds, 3-Ring
Humans
Retrospective Studies

Substances

Anti-Bacterial Agents
Heterocyclic Compounds, 3-Ring
upadacitinib